{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:04:20Z","timestamp":1719187460572},"reference-count":22,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2016,1,31]]},"DOI":"10.2217\/fon.15.299","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T11:33:15Z","timestamp":1448883195000},"page":"143-147","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Updates from the Neuro-Oncology Section of the 2015 American Neurological Association Annual Meeting"],"prefix":"10.1080","volume":"12","author":[{"given":"Rimas V","family":"Lukas","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Chicago, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek A","family":"Wainwright","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Northwestern University, Chicago, IL, USA"},{"name":"Northwestern Brain Tumor Institute, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J","family":"Laterra","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University, Baltimore, MD, USA"},{"name":"Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm934"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e31828cf945"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2130"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1517"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3314"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou307"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70090-6"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28780"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1082027"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1748-7"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","unstructured":"Zhai L DeyM LauingKLet al. The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy. J. Clin. Neurosci. (2015) (In Press).","DOI":"10.1016\/j.jocn.2015.06.018"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2025"},{"key":"e_1_3_2_15_1","unstructured":"Allen Brain Atlas\n. www.brain-map.org."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3182829903"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0514"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq157"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.8072","article-title":"A Phase I study of nivolumab (anti-PD1; BMS-936558; ONO-4538) plus platinum-based doublet chemotherapy (PT-doublet) in chemotherapy-na\u00efve non-small cell lung cancer (NSCLC) patients (pts)","volume":"31","author":"Rizvi NA","year":"2013","unstructured":"Rizvi NA , AntoniaSJ, ChowLQMet al. A Phase I study of nivolumab (anti-PD1; BMS-936558; ONO-4538) plus platinum-based doublet chemotherapy (PT-doublet) in chemotherapy-na\u00efve non-small cell lung cancer (NSCLC) patients (pts). J. Clin. Oncol.31(Suppl), Abstract 8072 (2013).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24523"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70489-9"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24523"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24498"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.15.299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:54Z","timestamp":1719124974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.15.299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1,31]]}},"alternative-id":["10.2217\/fon.15.299"],"URL":"https:\/\/doi.org\/10.2217\/fon.15.299","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-10-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}